Ga-68 PSMA-11 PET/MRI improves prostate cancer detection
PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) could become a valuable tool in image-guided biopsy and for detecting significant prostate cancer, researchers reported on Wednesday at ECR 2019. {read more here}
New drug delivery system, verified with PET imaging, could also be used to treat brain tumors and strokes. {read more here}
In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy. {read more here}
In patients with primary Sjogren syndrome (pSS), a lymphoma diagnosis was associated with focal lung lesions or maximum parotid gland uptake on Fluorine 18 (18F) fluorodeoxyglucose (FDG) positron emission tomography with computed tomography (PET-CT), according to a report published in Arthritis & Rheumatology. {read more here}